[6-K] BRASKEM SA Current Report (Foreign Issuer)
Braskem S.A. furnished a Form 6‑K providing monthly disclosure related to securities and derivatives activity and shares held in treasury, prepared in accordance with Brazilian CVM Instruction 358/2002 as amended by Instruction 568/2015. The report covers October 2025 and references Class “A” preferred shares and treasury share positions.
The company confirms it files annual reports on Form 20‑F and indicates “No” for Rule 12g3‑2(b) treatment. The filing includes standard forward‑looking statements language and is signed by Chief Financial Officer Felipe Montoro Jens on November 7, 2025.
- None.
- None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2025
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
In October/25 ( ) ( x ) Securities/Derivatives Securities Characteristics Intermediate Operation Day Quantity Price Volume (R$) INDIVIDUAL FORM SHARES HELD IN TREASURY(Article 11 of CVM Instruction # 358/2002, amended by Article I of CVM Instruction # 568/2015) the only operations with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002, amended by Article I of CVM Instruction # 568/2015 no operation with securities and derivatives, in compliance with Article 11 - CVM Instruction # 358/2002, Opening Balance 42.150.391/0001-70 Corporate Taxpayers ID Company’s Name: Braskem S.A. amended by Article I of CVM Instruction # 568/2015, were held. Below are the securities and derivatives held by Braskem S.A. Name: Braskem S.A. 27 Quantity Quantity Qualification: Shares in Treasury Share Class “A” Preferred Share Closing Balance Securities/Derivatives Securities Characteristics Trading in the month 27 Securities/Derivatives Securities Characteristics Share Class “A” Preferred Share
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 7, 2025
| BRASKEM S.A. | |||
| By: | /s/ Felipe Montoro Jens | ||
| Name: | Felipe Montoro Jens | ||
| Title: | Chief Financial Officer | ||
DISCLAIMER ON FORWARD-LOOKING STATEMENTS
This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.
FAQ
What did Braskem (BAK) file?
Braskem furnished a Form 6‑K with disclosures on securities/derivatives activity and treasury shares for October 2025.
Which annual report form does Braskem (BAK) use?
The company files annual reports on Form 20‑F.
Does this filing invoke Rule 12g3‑2(b) for Braskem (BAK)?
No. The filing indicates “No” for Rule 12g3‑2(b) treatment.
What period does the Braskem (BAK) disclosure cover?
The report covers October 2025 activity.
Which securities are referenced in the Braskem (BAK) report?
The report references Class “A” preferred shares and shares held in treasury.
Who signed the Braskem (BAK) Form 6‑K and when?
Felipe Montoro Jens, Chief Financial Officer, signed on November 7, 2025.
Which CVM rules are cited in the Braskem (BAK) disclosure?
CVM Instruction 358/2002, as amended by Instruction 568/2015.
